Advisory Board May 8, 2024

Currently, the vast majority of Alzheimer’s cases don’t have a clearly identified cause, but a new study published in Nature Medicine suggests that having two variants of the APOE4 gene could be the cause behind specific cases of the disease.

Top drivers of change in the neurodegenerative disease market

Study details

For the study, researchers analyzed pathological data from 3,297 brain donors and biomarkers and clinical data from 10,039 people, including over 500 people with two copies of APOE4, a gene variant that has long been known to increase a person’s risk of developing Alzheimer’s.

The researchers found that nearly every patient with two copies of APOE4 developed the biological pathology of Alzheimer’s. By age 55, more than 95% of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Survey / Study, Trends
CNS-Focused Rapport Therapeutics Preps IPO to Back Phase 2-Ready Epilepsy Drug
Balancing Weight-loss Medication Cost and Care
Marijuana rescheduling moves businesses into ‘uncharted territory’
Orforglipron: the new kid on the GLP-1 block
GLP-1 Agonist Safety Risks and Obesity Stigma with Kevin Peterson, MD, MPH

Share This Article